Sell-Side Consensus
Consensus as at 10/11/2021
| FY2022 | |
| CONTINUING OPERATIONS | |
| Underlying revenue growth (%) | |
| John Crane | 4 |
| Smiths Detection | 0 |
| Flex-Tek | 5 |
| Smiths Interconnect | 4 |
| Continuing Operations | 4 |
| Revenue (£m) | |
| John Crane | 901 |
| Smiths Detection | 717 |
| Flex-Tek | 554 |
| Smiths Interconnect | 321 |
| Continuing Operations | 2,493 |
| Operating profit (£m) | |
| Continuing Operations | 423 |
Continuing Operations excludes Smiths Medical which is accounted for as 'discontinued operations - businesses held for sale'.
Consensus is comprised of 8 analyst forecasts: JP Morgan, Goldman Sachs, BofA, Barclays, Citi, Exane BNPP, Investec, Stifel